Retina-Vitreous Consultants is honored to have been selected as one of only two clinical sites in New Jersey to participate in the COBALT Study. This phase 3 clinical research trial will investigate the use of bevasiranab, a novel small interfering RNA molecule, in the treatment of wet age-related macular degeneration. Please call our office at 973-716-0123 to determine if you may meet the eligibility criteria for inclusion in this study.

Patients who are randomized to the COBALT Trial will not incur any cost in their care for the duration of the study.

Retina-Vitreous Consultants, in conjunction with Macula Vision Research Foundation, will be hosting a free seminar for patients, family members, and individuals interested in learning about the newest research and treatments for Macular Degeneration, on Saturday, April 12, 2008 at the Livingston Senior/Community Center in Livingston, N.J. This seminar will begin at 9:00am and conclude at 10:30am. Questions from the audience will be encouraged. Free parking is available. Please call
1-866-462-2852 or 1-973-716-0123 for additional information.